1. Home
  2. WSC vs AMLX Comparison

WSC vs AMLX Comparison

Compare WSC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WillScot Mobile Mini Holdings Corp.

WSC

WillScot Mobile Mini Holdings Corp.

N/A

Current Price

$16.42

Market Cap

3.6B

Sector

Industrials

ML Signal

N/A

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

N/A

Current Price

$26.04

Market Cap

3.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WSC
AMLX
Founded
1944
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Corporate Leasing Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.8B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
WSC
AMLX
Price
$16.42
$26.04
Analyst Decision
Buy
Strong Buy
Analyst Count
10
11
Target Price
$25.20
★ $43.00
AVG Volume (30 Days)
★ 3.2M
1.3M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 1.49%
N/A
EPS Growth
N/A
★ 65.46
EPS
★ 0.70
N/A
Revenue
★ $2,281,446,000.00
$380,786,000.00
Revenue This Year
$2.69
N/A
Revenue Next Year
$2.24
$51,469.06
P/E Ratio
$26.92
★ N/A
Revenue Growth
N/A
★ 1612.94
52 Week Low
$15.57
$10.83
52 Week High
$29.77
$41.14

Technical Indicators

Market Signals
Indicator
WSC
AMLX
Relative Strength Index (RSI) 36.42 38.73
Support Level $16.23 $12.98
Resistance Level $18.73 $29.30
Average True Range (ATR) 1.16 1.84
MACD -0.22 -0.39
Stochastic Oscillator 2.85 7.71

Price Performance

Historical Comparison
WSC
AMLX

About WSC WillScot Mobile Mini Holdings Corp.

WillScot Holdings Corp designs, delivers, and services on-site, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company include modular office complexes, mobile offices, classrooms, blast-resistant modules, clearspan structures, sanitation solutions, portable storage containers, and climate-controlled containers and trailers.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: